These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 990151)

  • 21. Schizophrenia, psychotropic medication, and cataract.
    Gaynes BI
    Ophthalmology; 2000 Jan; 107(1):5-6. PubMed ID: 10647709
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of drug ritual changes on schizophrenic patients.
    Burgoyne RW
    Am J Psychiatry; 1976 Mar; 133(3):284-9. PubMed ID: 3979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of psychotropic drugs in the insidious deconstruction of the Kraepelinian dichotomy.
    Vinar O
    Psychiatr Danub; 2007 Dec; 19(4):354-8. PubMed ID: 18000488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What's new in the psychopharmacology of schizophrenia.
    Rifkin A; Quitkin F
    Bull N Y Acad Med; 1978 Oct; 54(9):869-78. PubMed ID: 280396
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative effectiveness of antipsychotic drugs.
    Osser DN; Akhter A
    Am J Psychiatry; 2003 Mar; 160(3):590; author reply 592-3. PubMed ID: 12611853
    [No Abstract]   [Full Text] [Related]  

  • 26. [Compliance must improve].
    Gastpas MT
    MMW Fortschr Med; 2006 Jan; 148(4):25. PubMed ID: 16502795
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term therapy of affective disorders and schizophrenia.
    Kielholz P
    Pharmakopsychiatr Neuropsychopharmakol; 1976 May; 9(3):93. PubMed ID: 981329
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmaco-epidemiology in 136 hospitalized schizophrenic patients.
    Zito JM; Craig TJ; Wanderling J; Siegel C
    Am J Psychiatry; 1987 Jun; 144(6):778-82. PubMed ID: 3592000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [10th Psychiatric World Congress. Madrid, August 1996. Schizophrenia: how to improve compliance].
    Psychiatr Prax; 1996 Nov; 23(6 Suppl Schizophre):1-4. PubMed ID: 9404536
    [No Abstract]   [Full Text] [Related]  

  • 30. [Associated psychotropic drugs in deficit schizophrenia].
    Beaufils B
    Encephale; 1996 Jun; 22 Spec No 2():41-3. PubMed ID: 8767041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical challenges in the psychopharmacology of schizophrenia.
    Fenton WS; Kane JM
    Schizophr Bull; 1997; 23(4):563-5. PubMed ID: 9365995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychotropic polypharmacy in Nigeria. The danger can be avoided and cost reduced.
    Famuyiwa OO
    Trop Doct; 1988 Jan; 18(1):7-11. PubMed ID: 3341093
    [No Abstract]   [Full Text] [Related]  

  • 33. [Benzamides, a therapeutic response adapted to 2 sides, paranoid and hebephrenic, of schizophrenia].
    Cassan P
    Ann Med Psychol (Paris); 1985 Jul; 143(7):677-82. PubMed ID: 2870674
    [No Abstract]   [Full Text] [Related]  

  • 34. [Perioperative management of patients on long-term administration of psychotropic drugs].
    Kudoh A; Kimura F; Murakawa T; Ishihara H; Matsuki A
    Masui; 1993 Jul; 42(7):1056-64. PubMed ID: 8350474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychiatric drug therapy. Pitfalls and how to avoid them.
    Ostow M
    N Y State J Med; 1978 Jul; 78(8):1221-7. PubMed ID: 276658
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical management of cardiovascular risks during treatment with psychotropic drugs.
    Glassman AH
    J Clin Psychiatry; 2002; 63 Suppl 9():12-7. PubMed ID: 12088171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic psychotropic drug treatment causes differential expression of connexin 43 and GFAP in frontal cortex of rats.
    Fatemi SH; Folsom TD; Reutiman TJ; Pandian T; Braun NN; Haug K
    Schizophr Res; 2008 Sep; 104(1-3):127-34. PubMed ID: 18585900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of psychopharmacologic therapy on heart rate variation].
    Rechlin T
    Nervenarzt; 1995 Sep; 66(9):678-85. PubMed ID: 7477605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New drug therapies].
    Olié JP; Baylé FJ
    Encephale; 1996 Oct; 22 Spec No 3():63-71; discussion 76. PubMed ID: 8954280
    [No Abstract]   [Full Text] [Related]  

  • 40. Limitations of controlled augmentation trials in schizophrenia.
    Stern RG; Schmeidler J; Davidson M
    Biol Psychiatry; 1997 Jul; 42(2):138-43. PubMed ID: 9209731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.